Immuneering (IMRX) Non Operating Investment Income (2021 - 2022)
Immuneering (IMRX) recorded quarterly Non Operating Investment Income of $112353.0 in Q4 2022, up 187.44% quarter-over-quarter from $39088.0 in Q3 2022, and up 353.86% on a YoY basis from $24755.0 in Q4 2021.
Immuneering (IMRX) Non Operating Investment Income (2021 - 2022) Analysis & Trends
Immuneering's Non Operating Investment Income history runs 2 years deep, the most recent figure standing at $112353.0 for Q4 2022.
- In Q4 2022, Non Operating Investment Income rose 353.86% year-over-year to $112353.0; the TTM figure through Dec 2022 stood at $18889.0 (changed N/A YoY), while the FY2022 annual figure was $18889.0, up 138.54% from the prior year.
- Non Operating Investment Income was $112353.0 for Q4 2022 at Immuneering, up from $39088.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $112353.0 in Q4 2022 to a low of -$118386.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 230,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Immuneering | 255.40 Mn | 255.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 112,353.00 |
| Dec 31, 2022 | 112,353.00 |
| Sep 30, 2022 | 39,088.00 |
| Sep 30, 2022 | 39,088.00 |
| Jun 30, 2022 | -14,166.00 |
| Jun 30, 2022 | -14,166.00 |
| Mar 31, 2022 | -118,386.00 |
| Mar 31, 2022 | -118,386.00 |
| Dec 31, 2021 | -44,258.00 |
| Dec 31, 2021 | -44,258.00 |
| Sep 30, 2021 | -4,751.00 |
| Sep 30, 2021 | -4,751.00 |